Riverwater Partners Reports Underperformance in 2025 Micro Opportunities Strategy
Riverwater Partners' Micro Opportunities Strategy underperformed benchmarks in Q4 and full-year 2025, citing underweight exposure in speculative areas. The strategy highlighted IRADIMED CORPORATION as its top performer.